Literature DB >> 19097762

Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis.

Beatrice Vitali, Federico Perna, Karen Lammers, Silvia Turroni, Paolo Gionchetti, Patrizia Brigidi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19097762     DOI： 10.1016/j.ijantimicag.2008.10.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  3 in total

1.  Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.

Authors:  Eric L Brown; Qiong Xue; Zhi-Dong Jiang; Yi Xu; Herbert L Dupont
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

Review 2.  Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.

Authors:  Francesca Romana Ponziani; Viviana Gerardi; Silvia Pecere; Francesca D'Aversa; Loris Lopetuso; Maria Assunta Zocco; Maurizio Pompili; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

3.  Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro.

Authors:  Kaitlyn Oliphant; Kyla Cochrane; Kathleen Schroeter; Michelle C Daigneault; Sandi Yen; Elena F Verdu; Emma Allen-Vercoe
Journal:  mSystems       Date:  2020-01-28       Impact factor: 6.496
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.